Report Detail

Pharma & Healthcare Global Crizotinib Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4751937
  • |
  • 05 October, 2026
  • |
  • Global
  • |
  • 97 Pages
  • |
  • GIR
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Crizotinib Drugs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Crizotinib is an oral medication that selectively blocks the activity of ALK and ROS1 receptors, which are involved in driving tumor growth and proliferation.Crizotinib is used primarily in the treatment of non-small cell lung cancer (NSCLC) that harbors specific genetic mutations.
This report is a detailed and comprehensive analysis for global Crizotinib Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Crizotinib Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Crizotinib Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Crizotinib Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Crizotinib Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Crizotinib Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Crizotinib Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Drug International, Genvio Pharma, Everest Pharmaceuticals, Azista, Beacom, Wanbang Biopharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Crizotinib Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Capsules
Oral Pellets
Market segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Major players covered
Pfizer
Drug International
Genvio Pharma
Everest Pharmaceuticals
Azista
Beacom
Wanbang Biopharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Crizotinib Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Crizotinib Drugs, with price, sales quantity, revenue, and global market share of Crizotinib Drugs from 2021 to 2026.
Chapter 3, the Crizotinib Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Crizotinib Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Crizotinib Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Crizotinib Drugs.
Chapter 14 and 15, to describe Crizotinib Drugs sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Crizotinib Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Capsules
    • 1.3.3 Oral Pellets
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Crizotinib Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital and Clinic
    • 1.4.3 Retail Pharmacies
    • 1.4.4 Other
  • 1.5 Global Crizotinib Drugs Market Size & Forecast
    • 1.5.1 Global Crizotinib Drugs Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Crizotinib Drugs Sales Quantity (2021-2032)
    • 1.5.3 Global Crizotinib Drugs Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Crizotinib Drugs Product and Services
    • 2.1.4 Pfizer Crizotinib Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 Drug International
    • 2.2.1 Drug International Details
    • 2.2.2 Drug International Major Business
    • 2.2.3 Drug International Crizotinib Drugs Product and Services
    • 2.2.4 Drug International Crizotinib Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Drug International Recent Developments/Updates
  • 2.3 Genvio Pharma
    • 2.3.1 Genvio Pharma Details
    • 2.3.2 Genvio Pharma Major Business
    • 2.3.3 Genvio Pharma Crizotinib Drugs Product and Services
    • 2.3.4 Genvio Pharma Crizotinib Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Genvio Pharma Recent Developments/Updates
  • 2.4 Everest Pharmaceuticals
    • 2.4.1 Everest Pharmaceuticals Details
    • 2.4.2 Everest Pharmaceuticals Major Business
    • 2.4.3 Everest Pharmaceuticals Crizotinib Drugs Product and Services
    • 2.4.4 Everest Pharmaceuticals Crizotinib Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Everest Pharmaceuticals Recent Developments/Updates
  • 2.5 Azista
    • 2.5.1 Azista Details
    • 2.5.2 Azista Major Business
    • 2.5.3 Azista Crizotinib Drugs Product and Services
    • 2.5.4 Azista Crizotinib Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Azista Recent Developments/Updates
  • 2.6 Beacom
    • 2.6.1 Beacom Details
    • 2.6.2 Beacom Major Business
    • 2.6.3 Beacom Crizotinib Drugs Product and Services
    • 2.6.4 Beacom Crizotinib Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Beacom Recent Developments/Updates
  • 2.7 Wanbang Biopharmaceuticals
    • 2.7.1 Wanbang Biopharmaceuticals Details
    • 2.7.2 Wanbang Biopharmaceuticals Major Business
    • 2.7.3 Wanbang Biopharmaceuticals Crizotinib Drugs Product and Services
    • 2.7.4 Wanbang Biopharmaceuticals Crizotinib Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Wanbang Biopharmaceuticals Recent Developments/Updates

3 Competitive Environment: Crizotinib Drugs by Manufacturer

  • 3.1 Global Crizotinib Drugs Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Crizotinib Drugs Revenue by Manufacturer (2021-2026)
  • 3.3 Global Crizotinib Drugs Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Crizotinib Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Crizotinib Drugs Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Crizotinib Drugs Manufacturer Market Share in 2025
  • 3.5 Crizotinib Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Crizotinib Drugs Market: Region Footprint
    • 3.5.2 Crizotinib Drugs Market: Company Product Type Footprint
    • 3.5.3 Crizotinib Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Crizotinib Drugs Market Size by Region
    • 4.1.1 Global Crizotinib Drugs Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Crizotinib Drugs Consumption Value by Region (2021-2032)
    • 4.1.3 Global Crizotinib Drugs Average Price by Region (2021-2032)
  • 4.2 North America Crizotinib Drugs Consumption Value (2021-2032)
  • 4.3 Europe Crizotinib Drugs Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Crizotinib Drugs Consumption Value (2021-2032)
  • 4.5 South America Crizotinib Drugs Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Crizotinib Drugs Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Crizotinib Drugs Sales Quantity by Type (2021-2032)
  • 5.2 Global Crizotinib Drugs Consumption Value by Type (2021-2032)
  • 5.3 Global Crizotinib Drugs Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Crizotinib Drugs Sales Quantity by Application (2021-2032)
  • 6.2 Global Crizotinib Drugs Consumption Value by Application (2021-2032)
  • 6.3 Global Crizotinib Drugs Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Crizotinib Drugs Sales Quantity by Type (2021-2032)
  • 7.2 North America Crizotinib Drugs Sales Quantity by Application (2021-2032)
  • 7.3 North America Crizotinib Drugs Market Size by Country
    • 7.3.1 North America Crizotinib Drugs Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Crizotinib Drugs Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Crizotinib Drugs Sales Quantity by Type (2021-2032)
  • 8.2 Europe Crizotinib Drugs Sales Quantity by Application (2021-2032)
  • 8.3 Europe Crizotinib Drugs Market Size by Country
    • 8.3.1 Europe Crizotinib Drugs Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Crizotinib Drugs Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Crizotinib Drugs Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Crizotinib Drugs Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Crizotinib Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Crizotinib Drugs Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Crizotinib Drugs Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Crizotinib Drugs Sales Quantity by Type (2021-2032)
  • 10.2 South America Crizotinib Drugs Sales Quantity by Application (2021-2032)
  • 10.3 South America Crizotinib Drugs Market Size by Country
    • 10.3.1 South America Crizotinib Drugs Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Crizotinib Drugs Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Crizotinib Drugs Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Crizotinib Drugs Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Crizotinib Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Crizotinib Drugs Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Crizotinib Drugs Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Crizotinib Drugs Market Drivers
  • 12.2 Crizotinib Drugs Market Restraints
  • 12.3 Crizotinib Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Crizotinib Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Crizotinib Drugs
  • 13.3 Crizotinib Drugs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Crizotinib Drugs Typical Distributors
  • 14.3 Crizotinib Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Crizotinib Drugs. Industry analysis & Market Report on Crizotinib Drugs is a syndicated market report, published as Global Crizotinib Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Crizotinib Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report